Continuous Glucose Monitoring (CGM) We do not recommend using CGM to diagnose hypoglycemia, as sensor glucose values are not as accurate as venous or capillary glucose in low ranges and may yield falsely low values
Bottom line Many insurance plans cover Wegovy for patients who fit the criteria and have met their deductible, but this can vary by plan
This early window is not universalsome individuals require 12 weeks before experiencing noticeable appetite reduction
Brand-Name Costs (Without Insurance): Monthly List Prices: Wegovy (semaglutide): $1,349 Ozempic (semaglutide): $969 Zepbound (tirzepatide): $1,069 Mounjaro (tirzepatide): $1,069 Saxenda (liraglutide): $1,400 Annual Costs: Semaglutide: $11,628-$16,188/year Tirzepatide: $12,828/year For 18-month treatment: $17,442-$24,282 These prices are unsustainable for most cash-pay patients